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Primary angiosarcoma of the ovary (AS) is a rare entity with only 31 reported cases. The majority are pure
angiosarcomas, the remainder are associated either with teratomas or conventional epithelial tumors. More than
50% of ovarian AS are disseminated at the time of diagnosis, the minority is detected in stage I. The prognosis of
ovarian angiosarcoma in general is poor. Most reports refer to younger individuals, aged from 7 to 46 years, and
only 2 case reports could be found for patients older than 64 years. Here we present a very unusual case of
angiosarcoma in a 81-year-old patient.
Background
Primary angiosarcomas (AS) of the ovary are rare malig-
nancies. Approximately 25% of them are associated with
other neoplasms, e.g. mature cystic teratoma, [1-3], muci-
nous cystadenoma, serous and mucinous carcinoma,
[4-6], or fibroma [7]. Metastases to the ovary from soft
tissue AS rarely occur [8,9]. 60% of all reported AS were
detected in stage III and IV [1-4,6,10-18]. Surgical
debulking and chemotherapy provided only short dis-
ease-free intervals, and most patients died from lung
metastasis within 9 months. Twelve reports with stage I
disease indicated better outcome, with only two patients
dying within one year [3,5,7,17,19-23]. Ovarian AS
usually affects premenopausal women or even children
[24], with only two reports in postmenopausal individuals
[7,18] (Table 1). Here we describe the oldest patient
reported with ovarian AS so far.
Case Presentation
Patient
The 81-year-old patient was admitted to the hospital
with abdominal pain and distension. Ultra-sonography
and computed tomography revealed a huge cystic mass
of the right ovary. There were no signs of distant tumor
deposits. The patient underwent hysterectomy and
adnexectomy on the right, the left adnexa had been
taken out decades ago. Further exploration of the abdo-
men and all other clinical investigations were without
pathological findings, six weeks after laparatomy the
patient underwent chemotherapy with 4 cycles of doxyr-
ubicin, and after an follow up of 5 months she is still
alive, and there are no signs of recurrence.
Macroscopically the tumor had a weight of 2122
grams and measured 30:18:12 cm. The peritoneal sur-
face was inconspicuous. The cut surface showed a big
central cyst with a diameter of 14 cm, containing
hemorrhagic debris and some luminal projections. The
cyst wall and its immediate surrounding consisted of
yellowish fibrous tissue with some myxoid glistening
changes and hemorrhagic areas, but no significant
necrosis (Figure 1). Microscopically, the cyst wall was
composed of fascicularly arranged, densely packed atypi-
cal spindle cells with pleomorphic nuclei and sparse
cytoplasm. Up to 4 mitoses per high power field were
counted. Focally, these spindle cells formed Kaposi-like
angiomatous spaces containing erythrocytes. Other
tumor components had a more epitheloid character. At
the periphery a thick fibrose zone was visible with some
edema and foci of well formed angiomatous prolifera-
tions, lined by atypical endothelial cells (Figure 2, 3, 4).
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grade malignant part of the lesion was restricted to the
immediate portion of the tumor surrounding the cyst,
whereas the angiomatous proliferation at the periphery
was much better differentiated. Intact fibrous ovarian
stroma could only be identified in areas bordering the
intact peritoneal capsule.
The central highly atypical fusiform tumor infiltrate
showed intense staining for CD31, reacted weakly for
WT1, but had lost expression of CD34. There were
nearly no remaining vascular spaces, and we found a
Mib-score of 60%. The more angiomatoid proliferation
in the periphery did express both, CD31 and CD34, and
Ki-67 was expressed only in some of the atypical
endothelial cells (Mib-score < 10%). HHV8, epithelial
markers (CK7, CAM 5.2, EMA), and smooth muscle
actin were negative. Fluorescent in situ hybridisation for
SYT-SSX (X; 18) was performed with LSI SYT Dual
Colour Break Apart probe (18q11.2, Abbott, North Chi-
cago, Illinois, USA) and was negative. Based on these
findings, the patient was diagnosed with primary angio-
sarcoma of the ovary, high grade.
Discussion
Ovarian angiosarcoma (AS) is with rare exceptions a
disease of premenopausal woman. Only two patients
have been reported in postmenopausal age [7,18] and
the 81 years old woman described in this report is the
oldest patient with this disease in the literature. AS of
the ovary is very rare with only two small case series
published so far, one with 4 and the other with 7 cases
[3,17]. In both publications ovarian AS were described
as morphological heterogenous tumors, a fact empha-
sized in a few other case reports too. The tumor
described in this report represented high grade AS only
in its central part, towards the periphery an atypical
Table 1 Survey of all reported cases of ovarian angiosarcoma including histologic type, stage, author, year of
publication and citation number
NR AGE HISTOLOGY STAGE AUTHOR YEAR CITATION
17 AS ? Evtushenko NT 1958 24
21 9 AS IV Cunningham MJ 1994 10
31 9 AS III Davidson B 2005 16
42 0 AS I Nielsen GP 1997 3
52 1 AS IV Bouchi J 1993 12
62 5 AS III Nucci MR 1998 17
72 5 AS III Lifschitz-Mercer B 1998 22
8 20-32 * AS I Nielsen GP 1997 3
9 20-32 * AS I Nielsen GP 1997 3
10 20-32 * AS I Nielsen GP 1997 3
11 20-32 * AS III Nielsen GP 1997 3
12 27 AS I Nucci MR 1998 17
13 28 AS I Jha S 2005 20
14 31 AS I Quesenberry CD 2005 21
15 33 AS IV Nara M 1996 15
16 35 AS IV Nucci MR 1998 17
17 38 AS IV Twu NF 1999 11
18 40 AS IV Platt JS 1999 14
19 42 AS IV Patel T 1991 13
20 42 AS I Nucci MR 1998 17
21 46 AS I Furihata M 1998 19
22 67 AS III Bradford L 2009 18
23 81 AS I Bösmüller H 2011
24 20-32 * Mature cystic teratoma + AS III Nielsen GP 1997 3
25 20-32 * Mature cystic teratoma + AS III Nielsen GP 1997 3
26 30 Mature cystic teratoma + AS III den Bakker MA 2006 2
27 32 Mature cystic teratoma + AS IV Contreras AL 2009 1
28 37 Mucinous cystadenocarcinoma + AS I Jylling AM 1999 5
29 45 Borderline serous cystadenocarcinoma + AS IV Pillay K 2001 6
30 77 Mucinous cystadenoma + AS III Ongkasuwan C 1982 4
31 65 Ovarian fibroma + AS I Cambruzzi E 2010 7
* age not specified.
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Page 2 of 6Figure 2 Transformation from centrally located angiosarcoma high grade (left) to more vasculated and well differentiated tumor
areas in the periphery; H&E 40×.
Figure 1 Cut surface of the right ovary featuring a centrally located tumor associated cyst.
Bösmüller et al. Diagnostic Pathology 2011, 6:65
http://www.diagnosticpathology.org/content/6/1/65
Page 3 of 6angiomatous proliferation was obvious, alternating with
areas of intense fibrosis. A Mib-score of 60% and the
marked pleomorphism with atypical mitotic figures in
the central areas are striking features for malignancy, so
there was no evidence for reactive angioma (Figure 5).
Massive fibrosis may obscure a malignant tumor, leading
to the misdiagnosis of fibroma or thecoma, similar to our
case in the frozen section diagnosis, but nevertheless AS
may coexist with true ovarian fibroma [7]. However, mas-
sive hemorrhage usually is present and suggests malig-
nancy. Fusiform and fibrous aspects together with only
sparse formation of capillary-like spaces, like in our tumor,
may focally mimic myogenous origin or metastasis,
respectively, but negativity of actin and expression of vas-
cular markers supported the diagnosis of angiosarcoma.
Synovial sarcoma was excluded by negative immunohisto-
chemical staining for epithelial markers and inconspicuous
SYT-SSX fluorescent in situ hybridisation [25].
Of 31 reported cases of ovarian angiosarcomas, 23
were pure lesions without coexisting benign or malig-
nant epithelial components. In 5 reports, angiosarcoma
was found to be associated with mature cystic teratoma,
and in this context it was discussed, whether angiosar-
coma is a sarcomatous teratoma, particularly those
tumors occurring in younger women[1-3]. In another 3
cases mucinous cystadenoma, mucinous cystadenocarci-
noma and borderline serous tumor were coexisting to
ovarian AS, rendering the diagnosis adenosarcoma and
carcinosarcoma, respectively [4-6], and putting ovarian
AS into the context of malignant mesodermal mixed
Figure 3 Centrally located angiosarcoma high grade with fusiform tumor component. CD31 staining 400×.
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Page 4 of 6tumor (MMMT) [22]. Angiosarcoma itself may show
epitheloid features and can therefore be mistaken for
carcinoma or metastasis, and one published case had a
predominant reticular growth pattern resembling yolk
sac tumor [17].
Conclusions
These examples show that the suspicion of ovarian AS
opens a broad range of differential diagnostic considera-
tions. The correct histopathological diagnosis, however,
is of importance because prognosis of ovarian AS is
Figure 4 Atypical vascular proliferation in the cortical areas of the ovary. CD31 staining 100×.
Figure 5 Centrally located high grade angiosarcoma exhibiting atypical mitosis; H&E 200×.
Bösmüller et al. Diagnostic Pathology 2011, 6:65
http://www.diagnosticpathology.org/content/6/1/65
Page 5 of 6uniformly poor. This could be related to the fact that
most patients are diagnosed with advanced disease in
stage III or IV. Although patients with stage I disease
were shown to survive and even become pregnant
[3,20], there are also reports on fatalities of patients
with early stage disease.
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